Enfortumab (Anti-Nectin-4)
Enfortumab (Anti-Nectin-4) (A2392-GRP)
Products
Description
Enfortumab (Anti-Nectin-4) is a monoclonal antibody targeting Nectin-4 and has potential for research into urothelial cancer. MW: 145.44 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2392 |